|

Bupivacaine-Epinephrine 0.5%-1:200,000 Injectable Solution Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Hamilton Health Sciences Corporation1

Indications

  • Pain, Postoperative1
  • Pituitary1
  • Cancer1

Other1 trial

Postop Pain Management in Pituitary Tumour Patients
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.